Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables rises 691.5% from a year ago
Net receivables stood at $192.47M at the end of Q2 FY2026, up 691.5% from a year earlier and up 42.8% from the prior quarter. Over 3 fiscal years it compounded at +98.0% a year.
Context
- Net receivables amounted to 10.0% of total assets at the end of Q2 FY2026, up 8.1 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +691.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 83.2M USD
- Year-over-year change
- +114.4%
- 3-year CAGR
- +98.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 83.2M | +114.4% |
| FY2024 | 2024-12-31 | 38.81M | +365.6% |
| FY2023 | 2023-12-31 | 8.34M | -22.3% |
| FY2022 | 2022-12-31 | 10.72M | — |
Net Receivables vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 net receivables of $192.47M is the 6th highest of the 7 companies compared; the peer median is $2.3B.
- Its year-over-year change of +691.5% is the highest of 7, against a peer median of +44.5%.
- Net receivables amounts to 10.0% of total assets for ALAB, versus a peer median of 8.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $3.75B | +9.3% | +5.9% | 14.4% | |
| Sep 2026 | $2.62B | +27.1% | +1.2% | 7.1% | |
| Aug 2026 | $2.39B | +53.8% | -7.3% | 4.9% | |
| Aug 2026 | $2.22B | +52.8% | +22.4% | 8.1% | |
| Aug 2026 | $288.8M | +50.4% | +58.2% | 9.6% | |
| Jun 2026 | $192.47M | +691.5% | +98.0% | 10.0% | |
| Sep 2026 | $73.38M | +38.6% | -35.4% | 8.0% | |
| Peer median (excluding ALAB) | $2.3B | +44.5% | +3.5% | 8.0% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.